loadpatents
name:-0.043216943740845
name:-0.020507097244263
name:-0.007328987121582
Friesen; Dwayne Thomas Patent Filings

Friesen; Dwayne Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Friesen; Dwayne Thomas.The latest application filed is for "acid resistant capsules".

Company Profile
9.22.38
  • Friesen; Dwayne Thomas - Bend OR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Process for forming active domains dispersed in a matrix
Grant 11,364,203 - Vodak , et al. June 21, 2
2022-06-21
Multiparticulates of spray-coated drug and polymer on a meltable core
Grant 11,116,728 - Friesen , et al. September 14, 2
2021-09-14
Acid Resistant Capsules
App 20210220285 - He; Xiongwei David ;   et al.
2021-07-22
Oral Rehydration Solution With Improved Taste
App 20200383354 - Friesen; Dwayne Thomas ;   et al.
2020-12-10
Oral rehydration solution with improved taste
Grant 10,653,168 - Friesen , et al.
2020-05-19
Colloidal dispersion comprising HPMCAS
Grant 10,471,152 - Cape , et al. Nov
2019-11-12
Multiparticulates Of Spray-coated Drug And Polymer On A Meltable Core
App 20190307702 - Friesen; Dwayne Thomas ;   et al.
2019-10-10
Spray drying processes for forming solid amorphous dispersions of drugs and polymers
Grant 10,383,941 - Beyerinck , et al. A
2019-08-20
Acid Resistant Capsules
App 20190240160 - He; Xiongwei David ;   et al.
2019-08-08
Multiparticulates of spray-coated drug and polymer on a meltable core
Grant 10,357,462 - Friesen , et al. July 23, 2
2019-07-23
Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
Grant 10,357,455 - Perlman , et al. July 23, 2
2019-07-23
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-forming Materials
App 20180338915 - Perlman; Michael E. ;   et al.
2018-11-29
Process For Forming Active Domains Dispersed In A Matrix
App 20180015041 - Vodak; David Thomas ;   et al.
2018-01-18
Novel Spray Nozzle And Process For Making Nanoparticles
App 20180000738 - Pansare; Vikram J. ;   et al.
2018-01-04
Colloidal Dispersion Comprising Hpmcas
App 20170281780 - Cape; Jonathan Leonard ;   et al.
2017-10-05
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-forming Materials
App 20170000733 - Perlman; Michael E. ;   et al.
2017-01-05
Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
Grant 9,486,410 - Perlman , et al. November 8, 2
2016-11-08
Solid compositions of low-solubility drugs and poloxamers
Grant 8,974,823 - Smithey , et al. March 10, 2
2015-03-10
Oral Rehydration Solution With Improved Taste
App 20140370144 - Friesen; Dwayne Thomas ;   et al.
2014-12-18
Oral Rehydration Solution With Improved Taste
App 20140370145 - Friesen; Dwayne Thomas ;   et al.
2014-12-18
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase
Grant 8,828,438 - Friesen , et al. September 9, 2
2014-09-09
Pharmaceutical compositions with enhanced performance
Grant 8,617,604 - Babcock , et al. December 31, 2
2013-12-31
Taste-masked drugs in rupturing multiparticulates
Grant 8,236,349 - Appel , et al. August 7, 2
2012-08-07
Multiparticulates Comprising Low-solubility Drugs And Carriers That Result In Rapid Drug Release
App 20110027372 - Appel; Leah Elizabeth ;   et al.
2011-02-03
Methods, Dosage Forms And Kits For Administering Ziprasidone Without Food
App 20110002989 - Curatolo; William John ;   et al.
2011-01-06
Dosage Forms Comprising Celecoxib Providing Both Rapid And Sustained Pain Relief
App 20100233272 - Appel; Leah Elizabeth ;   et al.
2010-09-16
Multiparticulate compositions with improved stability
Grant 7,736,672 - Ray , et al. June 15, 2
2010-06-15
Nanoparticles Comprising Non-crystalline Drug
App 20100119612 - Friesen; Dwayne Thomas ;   et al.
2010-05-13
Device for evaluation of pharmaceutical compositions
App 20100089186 - Babcock; Walter Christian ;   et al.
2010-04-15
Multiparticulates Of Spray-coated Drug And Polymer On A Meltable Core
App 20100068276 - Friesen; Dwayne Thomas ;   et al.
2010-03-18
Pharmaceutical Compositions Comprising Nanoparticles Comprising Enteric Polymers Casein
App 20100062073 - Beyerinck; Ronald Arthur ;   et al.
2010-03-11
Sustained Release Dosage Forms Of Ziprasidone
App 20100003331 - Ahmed; Imran ;   et al.
2010-01-07
Method and device for evaluation of pharmaceutical compositions
Grant 7,611,630 - Babcock , et al. November 3, 2
2009-11-03
Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
App 20090142401 - Appel; Leah Elizabeth ;   et al.
2009-06-04
Pharmaceutical Compositions Of Cholesteryl Ester Transfer Protein Inhibitors And Hmg-Coa Reductase
App 20090118328 - Friesen; Dwayne Thomas ;   et al.
2009-05-07
Pharmaceutical Compositions Comprising an Amorphous Form of a Vegf-R-Inhibitor
App 20080274192 - Friesen; Dwayne Thomas ;   et al.
2008-11-06
Fast-Disintegrating Microporous Binders
App 20080138428 - Ray; Roderick Jack ;   et al.
2008-06-12
Taste Making Formulation Comprising The Drug In A Dissolution-Retarded Form And/Or Cyclodextrin In A Dissolution-Enhanced Form
App 20080075784 - Friesen; Dwayne Thomas ;   et al.
2008-03-27
Pharmaceutical Compositions of Amorphous Dispersions of Drugs and Lipophilic Microphase-Forming Materials
App 20080063708 - Perlman; Michael E. ;   et al.
2008-03-13
Pharmaceutical Compositions with Enhanced Performance
App 20080064763 - Babcock; Walter Christian ;   et al.
2008-03-13
Azithromycin Dosage Forms With Reduced Side Effects
App 20080015343 - Hagen; Timothy A. ;   et al.
2008-01-17
Method And Device For Evaluation Of Pharmaceutical Compositions
App 20070205155 - Babcock; Walter Christian ;   et al.
2007-09-06
Taste-Masked Drugs in Rupturing Multiparticulates
App 20070196483 - Appel; Leah Elizabeth ;   et al.
2007-08-23
Sustained release dosage forms of ziprasidone
App 20070190129 - Ahmed; Imran ;   et al.
2007-08-16
Stabilized pharmaceutical solid compositions of low-solubility drugs and poloxamers, and stabilizing polymers
App 20070148232 - Crew; Marshall David ;   et al.
2007-06-28
Solid compositions of low-solubility drugs and poloxamers
App 20070141143 - Smithey; Daniel Tod ;   et al.
2007-06-21
Azithromycin dosage forms with reduced side effects
App 20060039988 - Hagen; Timothy A. ;   et al.
2006-02-23
Azithromycin dosage forms with reduced side effects
App 20060029677 - Hagen; Timothy A. ;   et al.
2006-02-09
Azithromycin dosage forms with reduced side effects
Grant 6,984,403 - Hagen , et al. January 10, 2
2006-01-10
Compositions comprising an HIV protease inhibitor
App 20050129772 - Smith, Scott Wendell ;   et al.
2005-06-16
Azithromycin dosage forms with reduced side effects
App 20050123627 - Hagen, Timothy A. ;   et al.
2005-06-09
Spray drying processes for forming solid amorphous dispersions of drugs and polymers
App 20050031692 - Beyerinck, Ronald Arthur ;   et al.
2005-02-10
Solubilized sertraline compositions
App 20040208926 - Friesen, Dwayne Thomas ;   et al.
2004-10-21
Sertraline salts and sustained-release dosage forms of sertraline
Grant 6,517,866 - Am Ende , et al. February 11, 2
2003-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed